Giuseppe Di Giovanni

Overview

Best Publications

• Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.

  Goran Šimić;Mirjana Babić Leko;Selina Wray;Charles Harrington

  760
  Citations

• Enhanced tonic GABAA inhibition in typical absence epilepsy

  David W. Cope;Giuseppe Di Giovanni;Giuseppe Di Giovanni;Sarah Jane Fyson;Gergely Orbán;Gergely Orbán

  460
  Citations

• SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

  Vincenzo Di Matteo;Giuseppe Di Giovanni;Michele Di Mascio;Ennio Esposito

  329
  Citations

• Serotonin in Animal Cognition and Behavior.

  Julien Bacqué-Cazenave;Rahul Bharatiya;Grégory Barrière;Jean-Paul Delbecque

  318
  Citations

• Monoaminergic neuropathology in Alzheimer's disease.

  Goran Šimić;Mirjana Babić Leko;Selina Wray;Charles R. Harrington

  300
  Citations

• Non-steroidal anti-inflammatory drugs in Parkinson's disease

  Ennio Esposito;Vincenzo Di Matteo;Arcangelo Benigno;Massimo Pierucci

  291
  Citations

• Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study

  Giuseppe Di Giovanni;Vincenzo Di Matteo;Michele Di Mascio;Ennio Esposito

  280
  Citations

• Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study.

  G Di Giovanni;P De Deurwaerdére;M Di Mascio;V Di Matteo

  270
  Citations

• Essential Thalamic Contribution to Slow Waves of Natural Sleep

  François David;Joscha T. Schmiedt;Joscha T. Schmiedt;Hannah L. Taylor;Gergely Orban

  261
  Citations

• International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

  Nicholas M. Barnes;Gerard P. Ahern;Carine Becamel;Joël Bockaert

  236
  Citations

• Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors

  Vincenzo Di Matteo;Giuseppe Di Giovanni;Michele Di Mascio;Ennio Esposito

  218
  Citations

• Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.

  Vincenzo Di Matteo;Giuseppe Di Giovanni;Massimo Pierucci;Ennio Esposito

  207
  Citations

• Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.

  Vincenzo Di Matteo;Massimo Pierucci;Ennio Esposito;Giuseppe Crescimanno

  195
  Citations

• Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

  Philippe De Deurwaerdère;Giuseppe Di Giovanni

  177
  Citations

• Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures

  Vincenzo Crunelli;Vincenzo Crunelli;Magor L Lőrincz;Magor L Lőrincz;Cian McCafferty;Régis C Lambert

  170
  Citations

• Serotonin-dopamine interaction: electrophysiological evidence.

  Giuseppe Di Giovanni;Vincenzo Di Matteo;Massimo Pierucci;Ennio Esposito

  162
  Citations

• Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens

  Vincenzo Di Matteo;Giuseppe Di Giovanni;Michele Di Mascio;Ennio Esposito

  159
  Citations

• Role of Serotonin in Central Dopamine Dysfunction

  Giuseppe Di Giovanni;Ennio Esposito;Vincenzo Di Matteo

  157
  Citations

• The central role of aquaporins in the pathophysiology of ischemic stroke

  Jasmine Vella;Christian Zammit;Giuseppe Di Giovanni;Richard Muscat

  156
  Citations

• m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors.

  G Di Giovanni;V Di Matteo;V La Grutta;E Esposito

  155
  Citations